Rapid Micro Biosystems (RPID) Operating Income Growth (1y) (2021 - 2026)
Rapid Micro Biosystems (RPID) Operating Income Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.43 Bn | 193.83 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 126.52 Bn | 123.04 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 52.20 Bn | 47.95 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.65 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.09 Bn | 22.61 Bn | 684.20 Mn | 16.18% |
| 10 | Rapid Micro Biosystems | 80.26 Mn | 60.49 Mn | 1.21 Mn | -1.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.43% |
| Mar 31, 2026 | -18.79% |
| Dec 31, 2025 | -19.38% |
| Sep 30, 2025 | 5.54% |
| Jun 30, 2025 | 9.19% |
| Mar 31, 2025 | 18.30% |
| Dec 31, 2024 | 16.07% |
| Sep 30, 2024 | 16.68% |
| Jun 30, 2024 | 11.13% |
| Mar 31, 2024 | 4.03% |
| Dec 31, 2023 | 29.39% |
| Sep 30, 2023 | 14.43% |
| Jun 30, 2023 | -6.96% |
| Mar 31, 2023 | 0.85% |
| Dec 31, 2022 | -18.58% |
| Sep 30, 2022 | -39.29% |
| Jun 30, 2022 | -29.57% |
| Mar 31, 2022 | -54.77% |
| Dec 31, 2021 | -49.83% |
| Sep 30, 2021 | -60.00% |